This site is intended for healthcare professionals only
LoginRegister
Centre Extends DCGI Rajeev Singh Raghuvanshis Tenure AgainDr. Rajeev Singh Raghuwanshi Reappointed as Drugs Controller India on Contract Basis
Pill form of Wegovy gets USFDA approval for weight lossNovo Nordisk Gets CDSCO Panel Nod To study CDR132L
USFDA Grants Tentative Approval, 180-Day Exclusivity to Granules Generic Amphetamine XRGranules India enters high growing peptide segment, CDMO business by acquiring Senn Chemicals
Morepen Labs Bags Rs 825 Crore Global CDMO DealMorepen Labs arm to form new subsidary
GSK Nucala application for COPD accepted for review in ChinaGSK Nucala application for COPD accepted for review in China
Gilead to Acquire Tubulis for USD 5 Billion to Strengthen Cancer PipelineGilead Seladelpar gets Conditional European Marketing Authorization for Primary Biliary Cholangitis
Zydus Chairman says Indian pharma players can deliver 100 new drugs by 2047Zydus Chairman says Indian pharma players can deliver 100 new drugs by 2047
Lupin, Natco Launch Bosentan Tablets in US With 180-Day ExclusivityLupin Gets Rs 18 Crore Relief as HC Bars Arbitrary Tax Reassessment
Zydus Lifesciences Slapped Rs 1.42 Crore Tax Demand, Plans to Challenge OrderZydus Lifesciences secures USFDA nod for Ibuprofen, Famotidine Tablets for rheumatoid arthritis
Abbott India Namita Shah - Associate Director - New Product Introduction and Therapy Area Strategy to step downAbbott India Namita Shah - Associate Director - New Product Introduction and Therapy Area Strategy...
Lupin Launches Dasatinib in US Market in Partnership with PharmascienceUSFDA issues EIR for Lupin Somerset facility
Sanofis Tetraxim Vaccine Gets CDSCO Panel Nod for Expanded IndicationSanofi nears selling 50 percent controlling stake in Opella to CD&R
X